Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
UCB
Pharma
J&J's Imaavy comes up short in rheumatoid arthritis study
Flying high after an FDA approval to treat gMG, J&J's Imaavy has come up short as part of a combination therapy in a rheumatoid arthritis trial.
Kevin Dunleavy
Aug 29, 2025 10:56am
Argenx pursues Vyvgart nod in seronegative myasthenia gravis
Aug 25, 2025 11:38am
FDA's response letter salvo sheds light on drug refusal process
Jul 11, 2025 10:15am
UCB extends Bimzelx campaign after hidradenitis suppurativa nod
Jul 8, 2025 11:33am
UCB's Fintepla shows potential to treat a 3rd epilepsy disorder
Jun 27, 2025 11:28am
UCB touts plan for 'major' US manufacturing investment
Jun 12, 2025 1:34pm
